News

Conference focuses on rapidly expanding field of sports cardiology and increasing demand for CV care teams who care for athletes

CRANBURY, N.J.--Rocket Pharmaceuticals, Inc., a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, announced that the European Commission (EC),...

St. Louis, May 29, 2024 – Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, today announces the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC)...

• Hong Kong selected as the pioneering international location for integrating Philips’ VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter into routine clinical practice • International roll-out underscores Philips’ commitment to...

SAN FRANCISCO -- WearLinq, a leading provider of wearable health monitoring and diagnosis solutions, today announced the acquisition of AMI Cardiac Monitoring, LLC, an established independent diagnostic testing facility (IDTF) with more than...

St. Louis, May. 22, 2024 – Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, has...

New Data Presented at Heart Rhythm Society Conference Demonstrates Continued Progress with Company’s AI Program Data Show That Applying AI to VCG Data Provides More Consistent and Reliable Detection of Atrial Flutter

LAGUNA HILLS, Calif. -- Adagio Medical, Inc. (“Adagio Medical”, “Adagio” or the “Company”), a leading innovator in catheter ablation technologies for ventricular tachycardia (“VT”) and atrial fibrillation (“AF”), today announced the...

New clinical trials demonstrate the safety and efficacy of improvements in cardiac implantable electronic devices and complementary pharmacotherapy

This physician-initiated prospective, randomized clinical trial sponsored by The National Heart, Lung, and Blood Institute found that early cardiac resynchronization therapy (CRT) may slow the progression of heart failure in patients with...